NEW YORK, October 10, 2018 /PRNewswire/ --
According to a report published by Oristep Consulting, the global medical cannabis market was valued at USD 12.67 Billion in 2016 and will reach USD 33.41 Billion by 2022 while growing
at a CAGR of 17.53% during the forecast period. The two main cannabinoids from the cannabis plant are THC and CBD, both are
widely used as treatments for various conditions such as lack of appetite, nausea, pain, inflammation (swelling and redness), as
well as muscle control problems. The report also indicates that by region, North America leads
the market, having held about half of the market share in 2016. As for the recreational cannabis segment, the spread of
legalization across North America is pushing its value projections to new highs. ICC
International Cannabis Corp. (OTC: KNHBF), Leafbuyer Technologies, Inc. (OTC: LBUY), AXIM Biotechnologies, Inc. (OTC: AXIM),
Invictus MD Strategies Corp. (OTC: IVITF), Auxly Cannabis Group Inc. (OTC: CBWTF)
The recent legislative victories for the cannabis industry are expected to have a highly positive impact on the economy. On
June 19th, Canada legalized cannabis across the nation.
Additionally, earlier this year, California began legal sales of cannabis products for
recreational use and since then, further political changes have been planned. "The cannabis sector currently employs an estimated
125,000 to 160,000 full-time workers," industry analyst and Editorial Vice President of MJBizDaily, Chris
Walsh, explained at The Marijuana Business Conference & Expo, according to a report from Fortune. "To put this in
perspective, there are potentially more full-time marijuana industry workers than there are librarians or kindergarten teachers
throughout the country - and over 6 times the number of coal miners in the U.S."
ICC International Cannabis Corp. (OTC: KNHBF) is also listed on the
Canadian Securities Exchange under the ticker (CSE: WRLD). Earlier today the company announced that it, "has been granted a
medical cannabis cultivation licence by the Greek government, superseding and augmenting its existing Hemp license. The licence
grant is a conditional pre-approval for medical Cannabis cultivation in the Greek prefecture of Imathia.
ICC controls a 16-acre land package situated in northern Greece, which will be dedicated to
medical grade cannabis cultivation, extraction, distribution, as well as research and development. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor
Cannabis cultivation. ICC's distribution network of approximately 35,000 pharmacies throughout 16 countries will complement the
company's Greek cultivation capabilities.
Greece is a European Union ("EU") member country and will operate as ICC's southern European
cultivation and production hub. The EU has a population of over 500 million, affording ICC with a unique opportunity to service
this high-growth marketplace. The service and tourism sectors amount to the majority of Greece's
economic output, contributing close to 85 per cent of annual gross domestic product. Approximately 16.5 million tourists visit
Greece each calendar year.
Eugene Beukman, chief executive officer and director of ICC, stated: "Receipt of the first
medical Cannabis cultivation licence to be issued by Greece represents a strong endorsement of
the Company's seed to sale initiatives globally, and in the EU in particular. This is a material milestone for both the industry
and the Company, of which International Cannabis is very proud. Greece is a favoured tourist
destination, which ICC believes could be the next great Cannabis holiday haven abroad. ICC's Greek contingent has been working
towards this licence for the past 18 months and has built long-term relationships with local officials and government ministers.
Through collaboration with ICC, Greece is presented with a unique opportunity to expedite the
realization of the benefits of a legalized cannabis industry."
In connection with the transaction, ICC will pay US $200,000 in cash and will issue 12,000,000
shares."
Leafbuyer Technologies, Inc. (OTCQB: LBUY) is a leading cannabis technology platform. Earlier this month, the Company
announced that yearly sales rose 42% in the fiscal year ended June 30th, 2018. The
increase reflects the cash sales booked in this year versus the previous year. The Company reported that sales in new markets
have been steadily increasing as marketing efforts have taken hold and sales staff have been put in place. "Our overall strategy
of broadening our platform to become a true comprehensive marketing solution has allowed us to attract many new customers and
upsell current ones. The average monthly spend for new customers has increased more than 50% in the last six months as we
continue to offer a wider basket of solutions. We have also been investing heavily in development (online ordering, loyalty and
block chain) and are starting to see the results in sales numbers." said Mark Breen, COO and VP of
Sales of Leafbuyer.
AXIM Biotechnologies, Inc. (OTCQB: AXIM) is an innovative biotechnology and pharmaceutical company focusing on
research, development and production of cannabinoid-based pharmaceutical and nutraceutical products. On September 13th, 2018, the Company announced that it has signed a Letter of Intent ("LOI") with
Impression Healthcare Limited, Australia's largest home dental impression company, for exclusive
distribution of all AXIM® Biotech products throughout Australia and New Zealand. Per the LOI, both parties will endeavor to co-develop new products, initially for pre-clinical
and phase 1 trials (among other clinical trials), including an oral rinse liquid targeted for the treatment of oral mucositis,
strep throat, oral infections and gum disease. Pending initial discussions and an internal review of AXIM® Biotech and its
product offerings, Impression will collaborate with the company for the licensing and distribution of its current and future
cannabinoid-based therapeutic products for distribution in Australia and New Zealand.
Invictus MD Strategies Corp. (OTCQX: IVITF) is a global cannabis company offering a selection of products under a wide
range of lifestyle brands. In late September, the Company announced that it had completed its first shipment of recreational
cannabis to British Columbia on time, following its inaugural shipment to Alberta. This significant milestone was made possible by the Company's balanced and deliberate approach
towards cultivation and regulatory compliance. While Invictus focused on expansion of its cultivation facilities, Acreage Pharms
secured excise stamps and Health Canada approved packaging for the adult recreational market early, allowing Purchase Orders to
be completed on time and without issue. To date, Invictus' wholly-owned subsidiary Acreage Pharms has secured provincial
agreements for the upcoming adult recreational market in British Columbia, Alberta and Saskatchewan, with others to follow-suit.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) is a collective of entrepreneurs with a passion for the cannabis industry
past, present and future. Earlier in September, the Company announced that further to its previously announced interim supply
agreement on January 17th, 2018, the Company, through its wholly owned subsidiary
Dosecann Inc., has entered into a definitive supply agreement with Aphria Inc. Pursuant to the Agreement, Dosecann will have the
option to purchase cannabis, including dried flower and cannabis oil for distribution to certain international markets, including
Mexico, Portugal, and Serbia, as well as a limited amount for
distribution into the Canadian market. Subject to Aphria receiving the necessary regulatory approvals for expansion of its
cultivation facilities, Dosecann will have the option to purchase up to 20,000 kilograms of Cannabis Products on an annual basis,
until such time, Dosecann will have the option to purchase up to 100 kilograms of Cannabis Products on a monthly basis.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For ICC International Cannabis Corp. corporate and financial news dissemination,
FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either
a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof.
The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near
the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for
financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or
continue to post information about any companies the information contained herein is not intended to be used as the basis for
investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is
not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for
any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other
materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of
their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance,
and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound
by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com.
For further information:
Media Contact: info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com